This page lists patient-reported quality of life surveys used in the field of medicine, pharmaceuticals, and other scientific trials. These surveys are patient-reported outcome measures, may be questionnaires or surveys, and may be used to evaluate patient satisfaction, symptoms, disease state, or psychological well-being.
List
Alzheimer's disease. The Quality of Life of Carers of Alzheimer's Disease Patients (ACQLI) is a measure which assesses the quality of life of people who care for Alzheimer's disease patients. It was developed in 1997 by Galen Research and has been used in studies investigating rosiglitazone and the effects of pharmacological treatment. Angina. The Seattle Angina Questionnaire (SAQ) measures five dimensions of coronary disease and consists of 19 items. The SAQ has been utilized in studies investigating spinal cord stimulation, ivabradine and ranolazine and refractory angina pectoris. Ankylosing spondylitis. The Ankylosing Spondylitis Quality of Life questionnaire (ASQoL) was developed Galen Research and published in 2003. It has been used in the evaluation of adalimumab and etanercept. Asthma. The Adult Asthma Quality of Life Questionnaire (AQLQ) was developed at McMaster University in Ontario, Canada and was published in 1992. It has since been used as a comparison tool as well as a tool in clinical trials. The Asthma Life Impact Scale (ALIS) measure was developed in 2010 by Galen Research. It has been translated into 16 languages. Atopic dermatitis. The Parents' Index of Quality of Life in Atopic Dermatitis (PiQOL-AD) measures the impact that atopic dermatitis has on quality of life, from the parents' perspective. It has 28 items and was developed simultaneously in the United Kingdom, The Netherlands, Germany, Italy, Spain, France and the United States. It has been utilised in several research studies investigating the treatment of paediatric atopic dermatitis with pimecrolimus. and also in a research study regarding health-related quality of life measurement in children in Ibero-American countries. The Quality of Life Index for Atopic Dermatitis (QoLIAD) measures the impact that atopic dermatitis has on a given patient's quality of life. It is a 25 item questionnaire for patients over the age of 16. The QoLIAD has also been utilized in studies looking into educational intervention, topical corticosteroids and pimecrolimus. Arthroplasty (Knee replacement).The Oxford knee score (OKS) is owned by Isis Outcomes and was developed at Oxford University. It was published in 1998. It has been validated for use in assessing other non-surgical treatments for issues of the knee. Chickenpox. The Family Disruption Measure for Chickenpox was developed in 1994 by Galen Research. It has been used in a study investigating rotavirus gastroenteritis. Chronic Otitis media. The Zurich Chronic Middle Ear Inventory (ZCMEI-21) has 21 questionnaires with answers as a 5-point Likert scale and measures health-related quality of life in chronic Otitis media with or without Cholesteatoma. It has originally been developed in German and has been translated into several languages, including English, Italian and Japanese.